Scancell (LON:SCLP) Shares Pass Above 50-Day Moving Average – What’s Next?
by Tristan Rich · The Markets DailyScancell Holdings plc (LON:SCLP – Get Free Report)’s share price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 16.65 and traded as high as GBX 23.50. Scancell shares last traded at GBX 22.50, with a volume of 418,329 shares traded.
Scancell Stock Up 0.4%
The stock has a fifty day moving average price of GBX 16.87 and a 200 day moving average price of GBX 13.43. The company has a debt-to-equity ratio of -193.29, a current ratio of 0.56 and a quick ratio of 13.01. The stock has a market capitalization of £234.54 million, a P/E ratio of -41.09 and a beta of 0.57.
About Scancell
Scancell (LSE:SCLP) is a clinical stage company leveraging two proprietary platforms, Immunobody® and Moditope®, to develop targeted off-the-shelf, patient-accessible active immunotherapies for a cancer-free future. The lead product iSCIB1+ is an Immunobody® DNA active immunotherapy that has demonstrated monotherapy activity in adjuvant melanoma. When combined with checkpoint therapies it showed additional clinical benefit over the checkpoints (CPI) alone in the ongoing Phase 2 SCOPE trial in advanced melanoma.